Objective To evaluate if embryo mosaicism is linked to poorer clinic pregnancy rates. Design Retrospective case-control study between January 2013 and January 2017. Materials and Methods Complete Chromosomal Screening (CCS) was performed on embryos of couples attending our fertility clinic between January 2013 and January 2017. In the first phase, array-CGH (aCGH) analyses were performed using the Agilent SurePrint platform G3 8 × 60 K CGH. Cells from the trophectoderm of the embryos were biopsied at the blastocyst stage (D + 5 or D + 6). We analyzed 1923 blastocysts from 704 cycles of IVF. An embryo was considered mosaic when the percentage of mosaicism was >25% and <80%. Embryos >80% were classified as aneuploid. Subsequently, embryos, in single embryo transfers previously diagnosed by array-CGH as euploid, were reanalyzed by NGS (n = 102). The chromosomal analysis was performed using the Veri-Seq Illumina kit and bioinformatic analysis was performed with the BlueFuse Multi software program (Illumina). Here an embryo was considered mosaic when the percentage of aneuploid cells was 20%-80%. Differences were assessed using the Chi-square test and binary logistic regression (SPSSv20.0).
Objective To evaluate if embryo mosaicism is linked to poorer clinic pregnancy rates. Design Retrospective case-control study between January 2013 and January 2017. Materials and Methods Complete Chromosomal Screening (CCS) was performed on embryos of couples attending our fertility clinic between January 2013 and January 2017. In the first phase, array-CGH (aCGH) analyses were performed using the Agilent SurePrint platform G3 8 × 60 K CGH. Cells from the trophectoderm of the embryos were biopsied at the blastocyst stage (D + 5 or D + 6). We analyzed 1923 blastocysts from 704 cycles of IVF. An embryo was considered mosaic when the percentage of mosaicism was >25% and <80%. Embryos >80% were classified as aneuploid. Subsequently, embryos, in single embryo transfers previously diagnosed by array-CGH as euploid, were reanalyzed by NGS (n = 102). The chromosomal analysis was performed using the Veri-Seq Illumina kit and bioinformatic analysis was performed with the BlueFuse Multi software program (Illumina). Here an embryo was considered mosaic when the percentage of aneuploid cells was 20%-80%. Differences were assessed using the Chi-square test and binary logistic regression (SPSSv20.0).
Results Clinical results were compared between cycles where euploid embryos with embryonic mosaicism were transferred and cycles in which only euploid embryos were transferred, both diagnosed by array-CGH. Both groups were homogenous, with no differences in implantation rates (26.9% vs. 40.3, P = 0.224), clinical miscarriages (7.1 vs. 18.1%, P = 0.354), biochemical miscarriages (21.2% vs. 12.3%, P = 0.102), clinical pregnancy rates (20.6% vs. 38.9%, P = 0.127). In a second phase, embryos previously diagnosed as euploid by array-CGH were reanalyzed by NGS (n = 102). In this group of 33 (32.4%) were found to be mosaic. Embryos from ongoing pregnancies demonstrated non-significantly lower mosaicism rates than failed cycles (23.1% vs. 38.1%, P = 0.115). In patients with repeated implantation failure and repeated pregnancy loss, percentages of mosaicism were also only non-significantly higher than in control group (27.8% vs. 20 .2%, P = 0.365; 41.7% vs. 27.4%, P = 0.123), and chemical and ongoing pregnancies also did not differ (16.7% vs. 23.1%, P = 0.743). Conclusions The management of mosaic embryos is still very controversial. The new techniques of CCS have given us better diagnostic power, allowing embryos previously classified as euploid with array-CGH to now with techniques such as NGS to be diagnosed as mosaic. After repeat analyses with NGS, this study found mosaicism in approximately one-third of previously by array-CGH reported euploid embryos. Mosaic embryos only demonstrated non-significant trends toward poorer IVF cycle outcomes, though lack of significance may reflect small cycle numbers. Though comparisons between mosaic and euploid embryos did not demonstrate significant outcome difference, transfer of mosaic embryos should, especially in RPL and RIF patients, still only be done cautiously. Support None.
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Immunotoxin to cell surface associated OOCYTE-SAS1B protein kills human uterine cancer cells Objective SAS1B (Ovastacin/ASTL) is an oocyte specific matrix metalloprotease. The goal was to examine the transcripts and proteins in uterine tumors and test SAS1B antibodies, including a prototype immunotoxin (Saporin), for their effect in vitro on growth and viability. Design Study examines: 1) SAS1B in normal oocyte biology and fertilization 2) internalization of cell-surface SAS1B 3) antibody-dependent cell cytotoxicity and 4) immunotoxin effects on tumor growth and viability. Materials and Methods Unique gene-specific primers were designed. An MMMT-derived cell line, SNU539, was used for cell-based experiments. A rabbit SAS1B-polyclonal antibody to cell cytotoxicity studies. Results SAS1B was found at message or protein levels in 77% of uterine tumors, with the incidence higher in MMMT tumors (87%, N = 16) than endometrioid carcinomas (74%, N = 59). SAS1B showed cell surface localization in live cells by immunofluorescence. Incubating SNU539 cells with SAS1B antibodies caused a transformation from a regular polygonal to rounded cells with redistributed actin cytoskeletons and shrinkage in diameter. When SNU539 cells were exposed to antibody under cold conditions followed by warming, antibody-SAS1B complexes were internalized into the cell cytoplasm where they co-localized with endocytic pathway markers EEA1/LAMP1. In a real-time cell-based assay using the XCELLigence system, tumor cells were killed in the presence of SAS1B-antibody and active complement. Inhibition of tumor cell growth and division followed by cell death occurred in culture over 72 h using a complex of SAS1B primary antibody and secondary immunotoxin conjugate. Conclusions SAS1B offers a candidate cell-surface target for development of a therapeutic tumor-selective antibody that is directed only to the tumor and an expendable population of mature oocytes thereby potentially reducing off target effects. Objective To evaluate if ICSI increase clinical outcomes compared to conventional IVF in couples with non-male factor infertility diagnosis according to WHO 2010. Design Retrospective cohort, observational study. Materials and Methods Setting: University Hospital IVF unit. Patients: sixty couples undergoing ART with nonmale factor infertility that used their own eggs inseminated with fresh ejaculated sperm either by ICSI (n = 28) or conventional IVF (n = 32) and have performed fresh blastocysts embryo transfers at day 5. Intervention: None. Main outcome measure (s): Fertilization rates (FR), quality of embryos transferred, clinical pregnancy rates (CPR), miscarriage rates (MCR), gestational age (GG) and live birthweight (LBW). Results No differences were found in women age, number of oocytes retrieved, oocytes inseminated, average of embryo transferred and FR between standard IVF and ICSI patients (36.69 ± 3.60 vs. 35.11 ± 3.48; 8.28 ± 5.06 vs. 9.71 ± 4.50; 6.66 ± 4.34 vs. 6.79 ± 3.02; 1.91 ± 0.39 vs. 1.93 ± 0.38 and 78.8% vs. 75.8%, respectively) . The number of top quality blastocysts achieved were equally in the two groups but poor quality blastocysts embryo transfers were higher in ICSI (27.8% vs. 14.8%, P = .0029). Despite this, clinical pregnancy rates (Odds Ratio 1.02, 95% IC 0.33-3.04) and miscarriage rates (Odds Ratio 4.01, 95% IC 0.15-6.48) were not statistical significantly different between ICSI and conventional IVF procedures. Both groups, showed no statistical significantly differences in GG and LBW (39.14 ± 0.90 vs. 37.15 ± 0.50 and 3685.71 ± 798.81 vs. 3312.50 ± 327.55 Objective The objective of our study was to determine if by vitrifying all embryos at day 3 and then transferring them at day five had a clinical impact on implantation and pregnancy rates. We hypothesized that an embryo that survive cryopreservation, thawing and continues to develop until day 5 in vitro, has a high potential of producing a pregnancy. Design Prospective longitudinal comparative study. Materials and Methods 207 patients under 40 years who underwent an assisted reproductive technology cycle from January 2014 to March 2017 were included. Group 1 (n = 131 patients, median age 34.9) received a fresh embryo transfer (239 embryos transferred). In Group 2, (n = 76 patients, median age 36.1) all day 3 embryos where vitrified (n = 191). In a posterior cycle 2-4 embryos were thawed and cultured to day 5 (n = 166). Two embryos per patient were selected for transfer in a hormone replacement cycle (n = 152). We did not perform any type of preimplantation genetic testing on the embryos. All embryos were transferred hatched, either spontaneously or by laser. Implantation and pregnancy rates between both groups were compared. Results The overall implantation and pregnancy rate was significantly higher in Group 2 compared with Group 1 (38.8% vs 16.6%, p = < 0.01) and (71% vs 39.50%, p = < 0.01) respectively. The multiple pregnancy rate showed an increase in Group 1 compared with the Group 2 but not significantly: 9.2% vs 13.65% and the abortion rate was 1.8% vs 0.02%, respectively. To date 42 children born from the 54 pregnancies of Group 2 and 33 from the 40 pregnancies of Group 1. All children were born healthy. Conclusions To our knowledge this is the first study to evaluate the clinical impact of vitrifying all day 3 embryos and transferring them hatched in a non-gonadotropin hyperstimulated cycle on day 5. Our findings suggest that transferring embryos with the capability to survive after cryopreservation, thawing and continue developing until day 5 in vitro, is associated with high implantation and pregnancy outcomes. It is tempting to speculate that the aptitude of the embryos selected by our approach, in addition to the avoidance of the supraphysiological hyperstimulated environment observed during controlled ovarian stimulation are the main causes of the high success rate. Furthermore, this approach may serve as a bioassay to determine embryo potential. Support None.
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Structural genomic aberrations, associated with reduced fertility and recurrent fetal anomalies Objective Structural genomic aberrations are usually associated with reduced fertility, recurrent abortions or fetal anomalies. Establishment of the exact genetic diagnosis in such cases has a great impact on the determination of reproductive risk and taking decision for reproductive options. Design In our study we have collected patient samples in following clinical cases of disturbed reproduction: infertility or repeated abortions, structural fetal anomalies and intrauterine death. Materials and Methods We have performed cytogenetic analysis in lymphocytes from couples in all these cases (488 samples) and array CGH analysis (microarray based Comparative Genomic Hybridization) of abortive materials in cases of disturbed fetal development (20 samples). Results Structural chromosomal rearrangements were established by cytogenetic analysis in 4 out of 258 women (1.6%), and in 3 out of 230 men (1.3%). Five of them were reciprocal translocations -46, ХХ, t(7; 10)(q11; p13); 46, XX, t(9; 11)(p23; p12); 46, ХХ, t(11; 22)(q23; q11.2); 46, XY, t(5, 6)(p13; q16); 46, ХУ, t(1; 11)(p36.1; q12), 1 was complex treeway translocation -46, XX, t(1p31-> 11q22-> 8q12-> 1p31) and 1 -ring chromosome 21. Array CGH revealed the following results: 17р13.3 microdeletion in a case of recurrent fetal lysencephaly; 1p36 microdeletion in a case of recurrent syndrome of multiple congenital anomalies; 22q11.21 microdeletion in a case of recurrent cono-truncal anomaly; 22q11.1 microduplication in a case of recurrent cat-eye syndrome; combined 10q26.3 microdeletion and 17q25.3 microduplication in a case of recurrent syndrome of mental retardation; 22q11.21 microduplication (diagnosed two times in the family) in a case of mosaic marker chromosome of the mother. Conclusions In about 1.5% of couples with reproductive failure structural chromosomal defects were detected. There is high probability (about 30%) to reveal microstructural genomic aberrations by array CGH in cases of recurrent fetal anomalies. Support None. Objective To test the hypothesis that Antral Follicle Count (AFC) and AntiMullerian Hormone (AMH) change across the menstrual cycle and are positively associated. Design Prospective, observational study. Materials and Methods The ovaries of 26 women (age 18-52) were ultrasonographically evaluated every 1-3 days for one complete interovulatory interval (IOI). At each visit, the numbers and diameters of follicles >2 mm were quantified. AFC was categorized for the following follicle diameter ranges: 2-10 mm, 2-5 mm, 4-6 mm, 5-8 mm, > 4 mm, > 5 mm and >6 mm. Blood samples were drawn every 1-3 days across the IOI to determine serum concentrations of AMH using a highly sensitive immunoassay (AMH (24/32) ELISA, Menopause. 2014 Menopause. 21:1277 . AFC and AMH across the IOI were graphed; rises and falls were quantified visually. A wave was defined as an increase in AFC or AMH followed by a successive decrease. Serial changes in mean AFC and AMH across the IOI were evaluated (SAS Proc Mixed). Beta binomial statistics were used to assess agreement between changes in AMH and AFC over the cycle. A measurement error of 10% was allowed for each endpoint. Results No changes in mean AFC and AMH across the IOI were detected (day effect: p > 0.05). However, when individual cycles were evaluated, 2-5 waves of AMH and AFC were detected. Agreement between AMH vs AFC over the IOI for follicles of varying diameters was as follows: 80% (2-5 mm), 80% (2-10 mm), 78% (4-6 mm), 74% (5-8 mm), 79% (>4 mm), 77% (>5 mm), and 79% (>6 mm). 3)] than in CG [6.0 IU (5.68-6.55), p = 0.0016, whereas women with endometriosis and Ala/Thr genotype had significantly higher levels (p = 0.001). Considering the response to COH, EDT had 3-fold less ovarian hyperstimulation syndrome (OHSS) than CG, however, this difference was not statistically significant. Women with endometriosis and Thr/Thr or Ser/Ser genotypes presented 3-fold more hyper response than CG (p = 0.037 and p = 0.014). Regarding IVF outcomes, women with minimal/mild EDT and Ala/Ala genotype produced smaller number of embryos than CG, p = 0.030. Comparing minimal/mild with moderate/severe EDT, women with Ser/ Ser genotype had minor oocytes retrieved (p = 0.018), and those with Ala/Thr (p = 0.039) or Ser/Ser (p = 0.044) genotypes presented fewer MII oocytes in moderate/severe EDT. Considering pregnancy rate no significant difference was found between EDT and CG, nor considering the genotypes of the polymorphisms studied. Conclusions FSHR Ala307Thr and Ser680Asn polymorphisms can determine different FSHR sensitivity influencing the IVF outcomes. Support FAPESP #2016/25953-9. Objective Endometriosis is a high prevalence gynecological disease that affects the reproductive potential of patients. Laparoscopic biopsy as gold standard for diagnosis is an invasive, expensive and operator-dependent procedure. Different research groups have proposed MicroRNA, a biomolecule that regulates various cellular processes, as a diagnostic marker of endometriosis. In this work we aim to explore, through a systematic review of published reports, which miRNA is a good candidate for screening in patients with suspected disease. Design Embase, Pubmed, BVS and SciELO were searched for relevant original papers between January 1993 (first report of microRNA in medical literature) and July 2016, using the following MeSH and DeCS terms: Bendometriosis^and BmicroRNA^. A total of 411 articles were found on the four databases. Papers included were written in English, Spanish, French and German. Studies conducted in vitro or animal models were eliminated. Case-control studies that compared microRNA in women with and without endometriosis were included if ranked as Bacceptable^or Bhigh quality^according to the SIGN checklist.
Conclusions
Materials and Methods Data were extracted by two independent reviewers. Papers chosen by each reviewer were compared and opinion differences were solved on consensus. Study characteristics, including population samples, inclusion and exclusion criteria, type of biological samples and biases were assessed. Results 21 articles were included. Nine miRNA (miR-135a, miR-199a, miR-141, miR-9, miR-200a, miR-200b, miR-20a, miR-191 and miR-17-5-p) with a significant statistical difference of expression between patients with and without endometriosis were reported by at least two different authors. Heterogeneity in the study design and in biological samples used for quantifying microRNA did not allow a meta-analysis of data. Conclusions Further research is needed before miRNA may become a validated diagnostic marker of endometriosis. Controlling biases and types of endometriosis studied is. In the meantime, laparoscopy as gold standard for diagnosis must be maintained. Support None. Objective The Signal Transducer and Activator of Transcription 4 gene (STAT4) is broadly implicated in several inflammatory and autoimmune diseases. A growing body of evidence indicates that immunological alterations are involved in the pathogenesis of endometriosis and autoimmune-related genes have emerged as possible candidates linked to disease development. Here, we aimed to evaluate a possible association between STAT4 polymorphisms (rs7601754/A > G, rs11889341/C > T, rs7574865/G > T e rs7582694/C > G) and the pathogenesis of endometriosis. Design Case-control study. Materials and Methods 439 women were studied: 174 infertile with endometriosis, 64 fertile with endometriosis and 201 fertile without endometriosis (control group). STAT4 polymorphisms were identified by real-time PCR using the TaqMan method. Genotype distribution and allele frequency were calculated, and haplotype analysis was performed. Results Individual analysis revealed an association between rs7601754 polymorphism and minimal/mild endometriosis in fertile women (G allele variant, p = 0.03). No association was found considering the polymorphisms rs11889341, rs7574865 and rs7582694 and endometriosis, even in fertile and infertile groups, or at different stages of the disease. The combined genotypes of the four polymorphisms identified the BGCGG^haplotype that was associated with protection against endometriosis and infertility ( p = 0 . 0 1 4 ) , w h e r e a s t h e h a p l o t y p e s BA C G C( p = 0.020), BAT T G^( p = 0.010) and BACTG( p = 0.032) were associated with risk of endometriosis and infertility. Conclusions Zamani et al. (2016) investigated the same STAT4 gene polymorphisms in 114 infertile women with endometriosis of Iranian descent and 92 controls. The results revealed an association between polymorphism rs7582694 (C allele) and endometriosis. The inconsistency between studies may be a result of the difference in ethnic composition and also in the selection of studied groups. The results suggest that the STAT4 rs7601754 polymorphism is involved in the susceptibility to minimal/mild endometriosis in fertile women and the haplotypes BACGC^, BATTG^and BACTG^are associated with risk of endometriosis and infertility, whereas the haplotype BGCGG^was associated with the protection against endometriosis and infertility. Support None. Objective Correlation of genetic disorders with human infertility. Design The population we studied in this preliminary effort, were 10 patients that were participating in a surrogacy IVF program and exhibited unexplained infertility. Specifically, these patients have had at least two fresh embryo transfers in oocyte donation cycles with no positive result. Materials and Methods We have chosen to apply an advanced clinical exome sequencing panel (powered by Sophia Genetics DDM) on an Illumina NextSeq-500 platform that analyses in detail at least11 Mb of human expressed DNA that contain more than 4500 genes with disease-causing mutations, according to the Human Gene Mutation Database (HGMD). We selected and targeted on 103 genes involved in human infertility, according to the Human Phenotype Ontology (HPO) database, which uses updated information from validated sources (Decipher, Orphanet, OMIM). Results Next generation sequencing and detailed bioinformatics analysis of the infertility related genes revealed pathogenic and/or likely pathogenic mutations in most of the infertile individuals. The number of samples analyzed is very small to draw conclusive results, but this pilot study suggests that genetic factors that predispose to various fertility related functions may play significant role in cases of repeated IVF failures. Conclusions Given the significant cost and health burden of repeated efforts for each surrogacy program this new genomic era offers a novel approach in selecting the couples that must think of alternative reproduction options. In a surrogacy program such a test is significant since there are legal aspects that might prevent the couple from even entering the program if the test shows a pathogenic mutation. Support None.
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The duration of the two-cell stage (p2) in euploid embryos that result in clinical pregnancy after frozen embryo transfer (FET) is shorter in embryos that had developed to blastocysts on day 5 versus day 6 of culture Objective Embryos that become blastocysts on day 5 of culture have been reported to have higher quality than those that become blastocysts on day 6. Our objective was to review time-lapse videos of thawed euploid embryos that resulted in clinical pregnancies to determine if duration of the 2-cell stage (P2) was shorter in embryos that became blastocysts on day 5 of the fresh cycle versus on day 6. Design Retrospective observational study of time-lapse videos of euploid embryos that resulted in clinical pregnancies after being thawed and transferred in a FET cycle. Materials and Methods After fertilization, two-pronuclear zygotes were placed into the Early Embryo Viability A s s e s s m e n t ( E e v a T M ) s y s t e m f o r t i m e -l a p s e morphokinetic analysis. Images were collected every 5 min until the time of embryo biopsy. Biopsy was performed on good quality embryos that had reached the blastocyst stage on day 5 or day 6 of culture. Blastocysts were vitrified, and the biopsied cells were sent to genetics lab for next generation sequencing for preimplantation genetic screening. Euploid embryos were transferred in subsequent FET cycles. Pregnant patients with a gestational sac and verified cardiac activity were identified, and the timelapse data of embryos competent to clinical pregnancy were retrospectively reviewed. An unpaired t-test was used to compare the P2 means between the day 5 vs day 6 blastocyts, with P < 0.05 considered to be statistically significant. Results When analyzing the P2 of euploid blastocysts that resulted in clinical pregnancies in the subsequent FET cycle, the average P2 (647.8 ± 11.5 min) of the competent embryos that had become blastocysts on day 5 (n = 29) was significantly shorter (p = .002) than the P2 (763.0 ± 24.5 min) of those competent embryos that had become blastocysts on day 6 (n = 7). Conclusions In thawed euploid embryos that resulted in clinical pregnancies, P2 was significantly shorter in embryos that had developed to the blastocyst on day 5 versus day 6 of culture. P2 may be an early indicator of faster-growing competent embryos and may be considered when selecting euploid embryos for transfer. Support None. Objective To investigate the human sperm oviduct interaction under near in vivo conditions. Design Cross-sectional study. Materials and Methods 1 cm sections of ampulla from 27 patients undergoing hysterectomy were inseminated with fresh or frozen/thawed sperm and the resulting interaction was examined qualitatively and quantitatively using newly established Live Cell Imaging technology. Pre and postmenopausal patients were divided into 3 groups. Group 1 (n = 9, oncology risk reduction surgery -control group), Group 2 (n = 9, post-operative diagnosis of malignant cancer) and Group 3 (n = 9, presence of ovarian cysts >2 cm). Samples were also fixed for scanning electron microscopy (SEM). All samples were obtained with ethical approval (Reference number: 1/378/1645) and informed patient consent.
Results Human sperm binding only occurs at the microvilli of secretory cells lining the fallopian tube. This binding is not only specific to the microvilli but is also transitory in nature lasting between 1 and 90 s. Sperm were observed to change the angle at which they were bound and were observed to compete for the same binding site. Binding was predominantly observed in spermatozoa with unaltered head morphology and high levels of plasma membrane integrity, both in frozen thawed and in fresh sperm. Inflammation or alterations of the fallopian tube reduce sperm binding and sperm survival time. In endometrial and cervical cancer patients, functional morphology of the tubal cells was distinctly affected. In these patients, sperm only bound to unaltered tubal cells. The presence of ovarian cysts did not negatively affect the formation of the sperm reservoir. Conclusions The formation of the human sperm reservoir has been documented for the first time under near in vivo conditions Sperm binding to the microvilli of the secretory cells is site-specific, temporary and competitive -this is unique in the human as compared to animal models. Even at the early stages of cancer, tubal functional integrity is affected resulting in compromised sperm-oviduct interaction. This knowledge could be used for establishment of new and early diagnostic methods for cancer detection. It is also very valuable to create new ideas for improving sperm fertilizing capacity in an in vitro fertilization (IVF) setting. Support None.
537
The impact of semen parameters and number of dominant follicles on the outcome of intrauterine insemination following superovulation with gonadotropins Results A total 1026 gonadotropins cycles were included. Among each individual semen parameter, IUI outcomes were affected by morphology only at 0% normal forms achieving no clinical pregnancy compared to CPR of 23.9% for a morphology ≥1% (p = 0.01). A total number of motile spermatozoa (TM) of ≥10 × 106 yielded a higher CPR compared to <10 × 106 (24.2 vs. 10.4%, respectively; p = 0.03). Furthermore, a total number of motile and morphologically normal (TMN) spermatozoa of >100.000 was associated with a higher CPR compared to <100.000 (24.3 vs. 2.7%, respectively; p = 0.001). The presence of >2 dominant follicles yielded a higher CPR compared to ≤2 follicles (31.2 vs. 20.6%, p = 0.001). Endometrial thickness did not correlate with IUI outcomes. Interestingly, women who developed a single dominant follicle required higher TM (45 × 106) and TMN (400.000) thresholds to achieve an optimal outcome. On the contrary, semen parameters did not affect the IUI outcomes for women with ≥2 follicles unless TMN was <100.000 (p = 0.02). Conclusions The total number of motile and morphologically normal spermatozoa synergizes with the number of follicles to optimize IUI outcomes following superovulation with gonadotropins. The lower availability of TMN spermatozoa can be counterbalanced by the number of dominant follicles. However, we suggest proceeding with in vitro fertilization should be recommended for couples with 0% normal morphology. Support None.
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Role of Interleukin-32 in the pathogenesis of endometriosis: in vitro, human, and transgenic mouse data Objective Endometriosis is characterized by a chronic inflammatory disease with several proinflammatory cytokines suggested to be involved in its pathogenesis and pathophysiology.
Interleukin-32 (IL-32), recognized as a new proinflammatory cytokine and a strong inducer of other proinflammatory cytokines, has been shown to serve as a key modulator in several chronic inflammatory diseases. This study aimed to investigate whether IL-32 plays a role in the pathogenesis of endometriosis.
Materials and Methods
In vitro experiments using Ishikawa cells and endometrial stromal cells (ESCs) were used to evaluate the effects of IL-32 (alpha and gamma) on proliferation (PCNA) and motility. In addition, IL-32 levels in the peritoneal fluid was compared between women with and without endometriosis using enzyme-linked immunosorbent assay. Experiments were conducted on IL-32 transgenic KO mice or wild-type mice after induction of endometriosis with ectopic endometriotic lesions of autologous endometrial transplants analyzed by immunohistochemistry for Ki-67 antigen and PCNA. Objective Early rise of serum progesterone level on the day of hCG administration is reported to be associated with impaired implantation and reduced birth rates in IVF-ET cycles. It is unclear whether altered progestogen levels influence on the early human embryonic development.
Design An in vitro study using human embryoid bodies (hEBs) as a surrogate of human embryo development, and mouse embryos. Materials and Methods The hEBs were cultured for 30 days, and were treated with progesterone or medroxyprogesterone acetate for 7 days. To reverse and evaluate the effects of progestogen treatment, mifepristone as progesterone antagonist was added to the hEBs for additional 7 days. For animal experiments, 6-week-old female C57/BL6 mice were mated with 8-week-old male mice and the retrieved embryos were cultured with progesterone for 48 h. To analyze the effects of progestogens on hEBs and mouse embryos, three differentiation marker genes representing the three-germ layers were chosen: α-fetoprotein (AFP) (endoderm), brachyury (mesoderm) and nestin (ectoderm). To measure the relative expression of differentiation marker genes, quantitative reverse transcription PCR (qRT-PCR) was performed. Results Significantly lower expression of brachyury and nestin was observed after treatment of progesterone in cultured hEBs (all P < 0.05). The lower expressions of brachyury and nestin by progesterone were negated by RU486 treatment. In mouse embryos, the expression of brachyury significantly decreased compared to the control after 24 h of progestogen treatment (P < 0.05). Objective Progesterone is an essential hormone in maintenance of embryo implantation and has been supplied in luteal phase after embryo transfer of In Vitro Fertilization (IVF) cycles. This study was aimed to evaluate whether serum progesterone level at early pregnancy period could predict the risk of pregnancy loss in IVF cycles. Design Observational study.
Materials and Methods Eighty five of IVF cycles recruited in this observational study had less than three previous attempts and showed positive serum human chorionic gonadotropin (hCG) at 2-week later after oocyte retrieval. All cycles were checked serum progesterone at the hCG check day. The cycles were follow up to 12-week of pregnancy age for evaluate pregnancy outcome. The area under the curve (AUC) of the progesterone level was analyzed to assess the risk of pregnancy loss. Results The overall ongoing pregnancy rate to 12-week of pregnancy age was 51.8% (44 of 85 cycles). The Cut-off value with serum hCG level higher than 89.8 mIU/mL and with serum progesterone level higher than 23.55 ng/mL could be predicting factors for on-going pregnancy (sensitivity = 0.98 and 0.66, specificity = 0.77 and 0.73, P < 0.0001 and P < 0.0001). When serum hCG level was higher than 89.8 mIU/mL, serum progesterone level lower than 28.25 ng/mL could be a predictor for pregnancy loss (sensitivity = 0.71 and specificity = 0.71, P = 0.019). Conclusions The serum progesterone level at 2-week later after oocyte retrieval could predict the risk of pregnancy loss in In Vitro Fertilization cycles, together with serum hCG level. The combined cut-off value of serum progesterone level higher than 25.2 ng/mL and serum hCG level higher than 126.5 ng/mL may suggest high pregnancy maintenance probability in IVF cycle. Support Supported by grants of Ministry of Science, ICT and Future Planning, Republic of Korea (2016R1E1A1A01943455 and 2016R1D1A1A02937287) . Objective To determines effects of mobile and on-line technologies on pelvic circulation and erectile dysfunction in males. Design Retrospective and prospective study. Materials and Methods We used an online system for patient education (http://www.rightdiet.ru), which relied on video lessons. They were humorous and contained pictures as well as cartoons to convey essential information on proper nutrition, necessity of exercises and the need for exposure to sunshine. Patients were also able to self-assess their sexual function with help of the newly translated (into Russian) European Male Aging Study Sexual Function Questionnaire (EMAS-SFQ), which not only defines deterioration of erectile function but also other aspects of male sexual health. A physician (endocrinologist-sexologists) was at all times on-call for study participants who had questions.
Results We here present data of 200 patients registered in the online system and of 40 controls group who received the same recommendations on the appointment. The average weight loss in the study group was 6.5 kg.
The study group also reported longer physical activity in comparison to controls (260 vs. 80 min per week, respectively). At time of this submission, final EMAS-SFQ profiles are not yet available; preliminary data, however, suggest that libido and sexual intercourse frequency increased in the study group. Conclusions This study reemphasizes the importance of making appropriate teaching materials available to patients. New online technologies have the potential of greatly improving availability of such materials for patients, thereby enhancing quality and duration of life of our patients. Support None. Objective Alpha-fetoprotein (AFP) is produced by the embryo/fetus. Our objective was to determine if AFP concentration in vaginal blood, in the setting of the passage of fetal tissue, is significantly higher than its concentration in the maternal serum. Design Case control study. Materials and Methods Four groups were evaluated: women with (1) incomplete/missed abortion with vaginal bleeding, (2) threatened abortion, (3) vaginal bleeding during cerclage placement, and (4) undergoing D&C. In each patient, AFP concentration in the vaginal blood or in the liquid component of the evacuated products of conception (POC; D&C group) was compared to the AFP concentration in the maternal serum. Results The median concentration ratios (and their ranges) of AFP in vaginal blood (or POC) to AFP in maternal serum were 24.5 (5.1-8620) and 957 (4.6-24,216) for the Incomplete/Missed (n = 30) and the D&C (n = 22) groups, respectively, whereas they were only 1.2 (0.4-13.4) and 1.01 (0.7-1.5) for the Threatened abortion (n = 15) and Cerclage (n = 9) groups, respectively. ROC analysis demonstrated 100% sensitivity and 86.7% specificity for the detection of the passage of fetal tissue (ratio 4.3, area under the curve 0.96). Conclusions Higher concentrations of AFP in vaginal blood than in maternal serum may indicate the passage of fetal tissue (i.e., confirming a failed pregnancy Objective To determine if nucleolar channel systems (NCSs) -markers of the implantation window -can be detected in exfoliated endometrial epithelial cells (EECs) of uterine secretions and to test if such minimally or non-invasively determined NCS status is associated with significant NCS prevalence in simultaneously obtained endometrial biopsies. Design Prospective study (Dec 2015 -Feb 2017 performed at university-affiliated and private fertility clinics with 43 lutealphase patients of reproductive age requiring endometrial biopsy for medical indications. Materials and Methods Uterine secretion was aspirated prior to endometrial biopsy. Cells in uterine secretions were spun onto slides and fixed. Biopsy tissue was fixed, paraffin-embedded, and sectioned. NCSs were identified and quantified in cells and tissue sections by indirect immunofluorescence. Initial specimens were used for method development (n = 21). Outcome measure was comparison of NCS status of uterine secretions with NCS prevalence in simultaneously obtained endometrial biopsies using the Mann-Whitney test. Based on NCS detection in exfoliated EECs, uterine secretions were assigned a status of NCSpositive (n = 15) or NCS-negative (n = 7). NCS prevalence in biopsies was expressed as percentage of NCSs per EECs. Results NCSs can be detected in exfoliated EECs of uterine secretions. Median NCS prevalence in endometrial biopsies from patients with NCS-positive uterine secretions was 41.9% (interquartile range, IQR 21.1-53.9) versus 2.0% (IQR 0-6.9) when secretions were NCS-negative. Consequently, the NCS status of uterine secretions identified a significant difference in NCS prevalence of simultaneously obtained biopsies (P = 0.0004; MannWhitney). Conclusions NCS status of uterine secretions accurately reflects the NCS prevalence in simultaneously obtained endometrial biopsies. Therefore and based on the facts that NCS prevalence in biopsies reliably marks the window of implantation and that uterine secretion aspiration is compatible with same-day embryo transfer (ET), our study provides proof of principle for a minimally invasive approach to determine maximal endometrial receptivity for timing frozen ET (FET Objective Several ovarian reserve tests have been proposed as predictors for the response to controlled ovarian hyperstimulation (COH), allowing individualized IVF treatment. The most valuable markers including age, FSH, antral follicle count (AFC) and AMH; however, a single parameter has a limited value and selecting one of these variables as a preferred marker in the clinical practice is still a controversial issue. Recently a new ovarian response prediction index (ORPI) based on AMH levels, AFC and age was reported. We evaluated the predictive value of age, FSH, AMH, AFC, ORPI for response to COH in IVF treatments. Design Cross-sectional study. Materials and Methods 188 infertile women (32.5 ± 3.4 yo) underwent the first cycle of ICSI/IFV treatment were studied. The infertility was mainly caused by male factor (n = 98), tubal factor (n = 59) and idiopathic (n = 31). All women were <38 yo, with normal FSH, TSH and prolactin levels, ovulatory cycles and BMI < 30. FSH and AMH levels were measured on the 3rd day of menstrual cycle by ELISA. The AFC was performed on both ovary and w a s c o n s i d e r e d f o l l i c l e s u p t o 1 0 m m . ORPI = (AMH × AFC)/patient age. Data analysis was carried out using univariate/multinomial logistic regression models and Akaike Information Criteria (AIC). Results Regarding the response to COH, 28.2% presented poor response; 59.6% good response and 12.2% hyper response. The mean age, AMH and FSH levels, AFC and ORPI for each group were, respectively: 32.2 ± 3,5 yo, AMH 3.9 ± 2.6 ng/mL, FSH 6.6 ± 2.1 mUI/mL, AFC 10.3 ± 3.4 and ORPI 1.44 ± 1.06 in poor response group; 33 ± 3.4 yo; AMH 3.9 ± 2.6 ng/mL; FSH 6.7 ± 2.0 mUI/ mL; AFC 9.2 ± 3.6 and ORPI 1.19 ± 0.95 considering the good response group, and 31.1 ± 3.7 yo; AMH 6.3 ± 2.0 ng/mL; FSH 5.1 ± 1.7 mUI/mL; AFC 12.2 ± 4.7 and ORPI 2.68 ± 1.5 in hyper response group. Comparison among groups revealed that women with hyper response were significantly younger, presented lower FSH and higher AMH, AFC and ORPI when compared to good response group. Regarding the predictive value of age, FSH, AMH, AFC, ORPI for the response to COH, all markers except age was capable to predict hyper response, although the best one was ORPI (AIC = 250.05). Conclusions FSH, AMH, AFC and ORPI were good predictors for hyper response to COH in IFV treatments; however, ORPI seems to be the best one. Support FAPESP# 2016/25953-9.
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The role of religion and spirituality in conceptualizing reproductive loss among gestational surrogates Objective It is well established that reproductive losses and failed ART treatment cycles leave women vulnerable to anxiety and depression. Losses within gestational surrogacy often go unacknowledged by the medical community, although gestational surrogates (GS) are particularly susceptible to feelings of failure given their proven history of fertility. This study seeks to understand how GS conceptualize and cope with reproductive losses associated with surrogacy, as this is critical for the consideration of their psychological wellbeing by health professionals who work with this unique population. Design Qualitative research using a grounded theory approach. Materials and Methods In-depth semi-structured interviews were conducted with study participants. Interviews were audiotaped and transcribed verbatim. Grounded theory analysis of data included line-by-line coding and emergent themes were identified. Results 17 GS had a total of 28 pregnancies. Reproductive losses associated with these pregnancies included 14 failed embryo transfers, 4 miscarriages, and 2 emergency hysterectomies. Additionally, 10 matches fell through (often for failed embryo transfers) and 3 instances of lost contact with intended parents and surrogacy children represented significant loss to the GS. Emergent themes included conceptualizing losses within a broader context of altruism and purpose. Some GS felt they were Bcalled^to surrogacy and that their surrogacy experiences were part of BGod's plan^that has shaped their future trajectory and provided existential meaning to their lives. One of the GS reflected on how she viewed losses both before and after her surrogacy experience in this way: BWhy, God…..why did you do this to me?....but now I look back and I'm starting to learn to say, 'Okay, God, I see why this is happening. What do you want me to learn from this?'Ĉ onclusions GS share no genetic connection to babies they carry and reproductive losses aren't always viewed as compassionately as for women who lose their Bown^pregnan-cies. However, GS may see their arrangements as being beyond a financial-based altruistic exchange and more of a Bcalling^. Recognizing and acknowledging losses associated within gestational surrogacy is important for the psychological wellbeing of GS. Utilizing religious/spiritual beliefs may be one way for health professionals to help GS grieve losses associated with their surrogacy experience. Support None. Objective The purpose of the present study was to evaluate the correlation between the concentration of antimullerian hormone (AMH) and the corresponding follicle volume during ovarian pick-up (OPU) in the frame of invitro fertilization (IVF) treatment. Design The study was designed and conducted at the Kinderwunsch Institut Schenk GmbH (Dobl, Austria). AMH concentrations and volumes of 24 follicles from 3 patients undergoing IVF treatment, in September and December 2016, were analyzed. Materials and Methods Women between 20 and 40 years old, undergoing IVF treatment were included in the study. Calculation of power and sample size was performed. Medical attendance and OPU was performed at the Kinderwunsch Institut Schenk GmbH. Informed consent was obtained beforehand. For each follicle, the follicular fluids (FF) were obtained and analyzed separately using the Steiner-Tan needle flushing system. AMH concentrations in FF were determined using electrochemiluminescence immunoassay (ECLIA). Results Testing for normal distribution (Kolmogorov-Smirnov test) revealed a normal distribution of all volumes analyzed (p = 0.028), but not of AMH concentrations (p = 0.306). Subsequent Spearman rank correlation found no significant relationship for follicular volume and the corresponding AMH concentration (r = −0.057, p = 0.791).
Conclusions FF is the environment for the growing oocyte and mirrors its metabolism. The fact that AMH concentrations do not correlate with the respective follicular volume makes it tempting to speculate that AMH may predict oocyte quality independent from the size of the follicle, thus, emphasizing AMH as potent biomarker in follicular fluid. Support None. Objective Does the change in the diameter along the needle from 17 to 20 G cause a change in the shear stress during the collection and affect the oocyte quality and embryo's development and morphokinetics? Design A prospective randomized study. Materials and Methods Ovaries were randomized to the aspirating needle. The embryologist was blinded to the needle. Oocyte was evaluated for 5 parameters: polar body, zona pellucida, cytoplasm, PVS and vacuoles. Results 256 oocytes were collected. Total of 118 oocytes were in the 17G group and 116 oocytes in 17-20G group. The total negative score per oocyte was significantly higher in the 17G group compare to the 17-20G (2.20 vs. 1.3; P = 0.002) No difference was recorded in the final morphology and the morphokinetics of the embryos. A presence of an abnormal or degenerative oocyte (total of 4 cycles) per cycle increased the total negative score for the oocytes and reduced fertilization rate (2.4 vs. 1.8; P = 0.021 and 70.7% vs. 56.1; P = 0.05). Conclusions Despite the difference between the shear stress in the two different needles, the oocytes collected with 17-20G needle had lower negative score compare to the 17G needle. Cycles with degenerative oocytes demonstrated worse oocyte quality and decrease in fertilization. Support None. Objective The pathogenic mechanisms by which varicocele disrupt spermatogenesis are not clearly understood, and it is possible that genetic causes may represent the actual etiological factor of male infertility. Over 30% of male infertility cases resulting from spermatogenic problems are associated with genetic abnormalities, and Y chromosome microdeletions are the second most frequent genetic cause of male infertility. Here, we aimed to evaluate the frequency of Y chromosome microdeletion in infertile men with varicocele. Design Cross-sectional study. Materials and Methods Fifty-one infertile men with varicocele (34.1 ± 7.1 years old) presenting non-obstructive azoospermia or severe oligozoospermia were screened to participate in this study. Y-chromosome microdeletion research was performed using polymerase chain reaction screening 20 regions involved in spermatogenesis (AZFa: sY746, sY84, sY86, DFFRY; AZFb: XKRY, sY118, sY113, sY127, sY134, sY143, RBM1Y and AZFc: sY153, sY148, sY157, sY158, sY254, sY255, sY160). Results Of the 51 participating men with infertility and varicocele, 64.7% had severe oligozoospermia, and 35.3% (18/ 51) had nonobstructive azoospermia. Y chromosome microdeletion was found in two cases (3.92%): one patient had azoospermia and complete microdeletion of the AZFb and AZFc regions, and another patient had severe oligozoospermia and complete microdeletion of the AZFc region. Conclusions Although in recent years, a genetic etiology related to Y chromosome microdeletions has become a major cause of infertility in males with spermatogenesis failures, in most of the studied patients, varicocele was the only cause of seminal abnormalities that could lead to infertility, suggesting that both varicocele and Y chromosome microdeletion, alone or combined, are etiological factors of male infertility. Support None.
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Three microRNAs in blastocyst culture medium as biomarkers for assessing the implantation potential of human embryos Objective The purpose of this study was to assess the MicroRNAs (miRNAs) expression in the spent blastocyst culture medium from implanted and non-implanted human embryos. Design Prospective cohort study. Materials and Methods The study design was to screen for miRNAs expression in an initial set of culture media samples from 31 high-grade embryos. The embryos were derived from good prognosis patients undergoing intracytoplasmic sperm injection (ICSI). All samples were prospectively collected on day five. Embryo transfers also were performed on day five. Culture media samples were split into two groups according to the embryo implantation result: positive implantation group (n = 16) and negative implantation group (n = 15). Total RNA was purified using miRCURY™ RNA Isolation Kit (Biofluids, Exiqon) and measured by fluorometer (Qubit). Preamplification step was performed using miScript PreAMP. Levels of 1066 miRNAs were evaluated with miRNome miScript miRNA PCR Array on 7900HT Fast Real-Time PCR System (Life technologies). The comparative Ct method was used to determine the relative expression of each miRNA in comparison with the normalizer. Ct = 30 was set as the threshold of detectability. Results A range of twenty miRNAs, including miR-1238-3p, miR-1260a, miR-1280, miR-1298, miR-133b, miR-1471, miR-3173-3p, miR-3201, miR-328, miR-3909, miR-425-3p, miR-489, miR-490-3p, miR-525-3p, miR-532-3p, mir-628-3p, miR-637, miR-720, miR-7-2-3p and miR-766-3p , were successfully amplified in all samples. Three miRNA (miR-337-3p; miR-3941; miR-3675-3p) were only detected in blastocyst medium from embryos with unsuccessful implantation. Conclusions Our results suggest that three specific miRNAs detected only in spent blastocyst culture medium from unsuccessfully implanted embryos could be usefully applied as biomarkers for non-invasive assessment of implantation potential of human embryos. Support This work was partially supported by Medical University -Sofia (Grant No. 346/15.01.2015) . Design This is a case report describing the effect of PBMC administration on patients with displaced window of implantation. Materials and Methods In order to find the implantation window the endometrial biopsies were taken during two subsequent natural menstrual cycles on day five after ovulation. Endometrial dating was performed with use of Noyes criteria and immunohistochemical assessment of estrogen and progesterone receptors. PBMC were obtained from the patient on the day of ovulation and were cultured with hCG for 48 h. Two days later, PBMC were freshly isolated from the patient again, combined with the cultured PBMC and then administered to the intrauterine cavity of the patient. The second endometrial biopsy was taken 3 days after the administration of PMBC and 5 days post-ovulation. Results Three women with recurrent implantation failure (RIF), previously classified as idiopathic have been subjected to an endometrial dating procedure. As a result, they were diagnosed as having a significant displacement of implantation window which was suggested to be 4 days after the biopsy and 9 days after ovulation, respectively. The administration of intrauterine PBMC was performed as a standard treatment procedure for patients with RIF in our clinic. The second endometrial biopsies were taken 3 days after the PBMC administration. The performed endometrial dating revealed that the window of implantation was not displaced anymore and it was at day 5 postovulation in all three women. Several months later, two of them achieved successful pregnancy after PBMC administration followed by single embryo transfer. Conclusions Our results suggest that intrauterine administration of autologous PBMC could shorten the time between ovulation and the appearance of implantation window. Therefore, it may be an effective approach for treatment of women with displaced window of implantation and its application should be taken into account when choosing the right time for embryo transfer. Support None.
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Kinetics analysis of estradiol in HIV-infected women stimulated for IVF/ICSI. Objective Thanks to the effectiveness of highly active antiretroviral therapy (HAART), people infected with the Human Immunodeficiency Virus (HIV) can now enjoy a greater quality of life and may wish a parenting project. Ovarian dysfunction has been described in HIV positive women. Some studies report a poor response in in vitro fertilization (IVF) protocols. Conversely, other studies show no impact of viral infection on ovarian function. Design We have analyzed the kinetics of estradiol in response to controlled ovarian hyperstimulation (COH) before IVF, associated or not with intracytoplasmic sperm injection (ICSI) in HIV-infected women and HIV-uninfected women. Materials and Methods This is a retrospective monocentric study including 63 seropositive patients compared to 1194 seronegative patients treated at the center of Rennes University Hospital between 2008 and 2015. We have also analyzed the impact of antiretroviral therapy on this kinetics. HIV-infected patients were divided into three groups: a group of untreated patients before stimulation, a group having HAART, including a boosted protease inhibitor (PI) and a boosted PI-free group. Results Following adjustment on several criteria (age, tobacco consumption, type of protocol, type of infertility, body mass index, initial dose of gonadotropins and Anti-Müllerian hormone level), there was no difference between seronegative and seropositive patients in the kinetics of estradiol during COH, or on the number of mature oocytes. Nevertheless, HIV-positive women required management with higher doses of gonadotropins. When taking into account the HAART regimen (with or without protease inhibitors), untreated infected patients had more total oocytes collected (p < 0.005), but similar number of mature oocytes. Conclusions Our results do not evidence any deleterious effect of HAART on ovarian function in HIV+ women. Support None. Objective Pregnancies following bone marrow transplant are rare in view of the use of alkylating agents and/ or total body irradiation before transplantation. This report evaluates a spontaneous pregnancy after prepubertal bone marrow transplant at the age of 11 years and reviews literatures about fertility prognosis in patients with a prior bone marrow transplant. Design Case report with review of literature over 20 years. Materials and Methods A 34 years old nulliparous woman with a history of aplastic anemia, treated with bone marrow transplant at the age of 11 (prepubertal) came to us for subfertility evaluation. Prior to the transplant, she had high dose cyclophosphamide (cumulative dose 65 g) and total body irradiation. She was given cyclosporine A and methotrexate post transplantation. Post operatively, she developed sepsis and recovered uneventfully. She attained spontaneous puberty 2 years later at 13 years of age. She was married for 6 years and consulted us for fertility. Her cycles were every 21 days and her husband's semen was unremarkable. Her FSH was 12.5 with a low antral follicle count of 8. She was offered in vitro fertilization (IVF) in view of the poor ovarian reserve and underwent a hysteroscopy polypectomy for a 0.8 cm endometrial polyp. However she conceived immediately in the next cycle while awaiting IVF workup. We reviewed literature over the past 20 years to identify fertility outcome after BMT. Results Bone marrow transplant is known to reduce fertility in long-term survivors and the overall pregnancy rate after bone marrow transplant was 0.6%. Total body irradiation prior to transplant is incapacitating causing a hypergonadotrophic ovarian failure. Patients' age influenced the recovery and pregnancy rate was markedly reduce when the bone marrow transplant occur on the later age (> 20 years old). Pubertal onset may be delayed or may not occur after bone marrow transplant. Miscarriage rates are associated with higher TBI and there is an association with preterm births. Conclusions Spontaneous pregnancy after bone marrow transplant is rare and is associated with higher adverse outcomes. There is a high incidence of gonadal dysfunction in these patients. Fertility preservation is strongly encouraged for these individuals prior to the incapacitating therapy. Careful follow up of the subsequent pregnancy is essential. Support None.
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The impact of FSHR gene polymorphisms Ala307Thr and Asn680Ser in the endometriosis development Results Single-marker analysis revealed no significant difference for both Ala307Thr and Asn680Ser polymorphisms between endometriosis and control groups. However, when the endometriosis group was subdivided according to fertility status and disease stage a positive association was found among 307Ala/Ala or GG genotype (p = 0.026, OR = 2.00, 95% CI = 1.08-3.73) and 680Ser/Ser or GG genotype (p = 0.004, OR = 2.84, CI 95% = 1.36-5.93) and fertile women with moderate/severe endometriosis when compared to control group. Combined alleles of FSHR polymorphisms revealed a BGG/307Ala680Ser^haplotype also associated to endometriosis progression in fertile women (p = 0.005), while BGA/ 307Ala680Asn^haplotype was associated to protection against endometriosis development (p = <0.001), regardless the fertility status and the stage of the disease. Conclusions The findings suggest that 307Ala/Ala or GG genotype, 680 Ser/Ser or GG genotype and BGG/ 307Ala680Ser^haplotype increase the risk of endometriosis progression in fertile women, while BGA/307Ala680Asnĥ aplotype decreases the risk of endometriosis development, regardless the fertility status and the stage of the disease. Support FAPESP #2016/25953-9 and #2017/01202-7. 
, Fernando Fonseca
Objective To compare repeated doses of GnRHa with a single bolus of 50 mcg hCG as luteal phase support for patients treated with GnRHa trigger for ovulation. Design Prospective randomized controlled study. Materials and Methods Patients at-risk for developing OHSS were treated with GnRH antagonist protocol and a GnRHa trigger for ovulation. An E2 level ≥ 2500 pg/ml was used to trigger ovulation with GnRHa instead of the classic hCG trigger. Patients were randomized to receive a single bolus of 50 mcg hCG on day 3 following oocyte pick-up or repeated doses of GnRHa (decapeptyl) 0.1 mg every 2 days from day 3 following oocyte pick until pregnancy test. Results Both groups were comparable in age, BMI and E2 at hCG, as well as in number of oocytes retrieved. Progesterone levels increased from day 3 to day 6 (from 27.2 ± 14 to 48.5 ± 32 ng/ml in GnRHa group and from 23.2 ± 28 to 45.7 ± 20 ng/ml in the hCG group). LH level on day 6 was higher in the GnRHa group compared to the hCG group (3.0 ± 2 vs. 0.22 ± 0.1 IU/l, P = 0.01). Clinical pregnancy rates were 45% in the GnRHa group and 44% in the hCG group (P = 0.57). OHSS was reported in one in hCG group patient. Conclusions Both strategies seem to be efficacious for luteal phase support. Repeated GnRHa doses seem to be safer. Support None. Objective The aim of the research was to determine reliable prognostic tools for predicting ovarian hyperstimulation syndrome (OHSS) in assisted reproductive technologies (ART), and to establish cut-off levels of the most significant laboratory findings associated with the development of OHSS. Design The study included 276 infertile women that underwent in vitro fertilization (IVF), in BCenter of Reproductive Medicine^(Minsk, Belarus) during 2014-2016. Materials and Methods The following parameters were assessed: age, body mass index (BMI), antral follicle count (AFC), serum levels of the following substances before the start of controlled ovarian stimulation: follicle stimulating hormone (FSH), luteinizing hormone (LH), anti-Mullerian hormone (AMH), thyroid stimulating hormone (TSH), anti-thyroid peroxidase antibodies (anti-TPO antibodies), glucose, and insulin. Also, the homeostatic model assessment (HOMA) was performed. Controlled ovarian stimulation (COS) was carried out with the use of GnRH agonist protocol. ART included IVF + intracytoplasmic sperm injection (ICSI), and embryo transfer on day 5 after follicle aspiration (blastocyst stage). Results Moderate OHSS occurred in 24 cases (8.70%); pregnancy rate was 42.4% (117 IVF cases). ROC-curve was used to assess the prognostic value of the examined parameters. The most reliable markers of OHSS were the following: AMH (cutoff value 3.6 ng/ml; AUC 0.896; sensitivity 91.7; specificity 84.93; PPV 36.7; NPV 99.1; p < 0.0001); anti-TPO antibodies (cutoff value 369,41 IU/ml; AUC 0.866; sensitivity 83.33; specificity 88.5; PPV 40.8; NPV 98.2; p < 0.0001); and HOMA (cutoff value 369.41 IU/ml; AUC 0.866; sensitivity 83.33; specificity 84.13; PPV 33.3; NPV 98.1; p < 0.0001). Logistic regression model was used to assess the examined parameters in terms of their value in OHSS prediction. The following parameters proved to be the most valuable: AMH (OR 2.6852, P < 0.0029); anti-TPO antibodies (OR 1.0103, P < 0.0003); and HOMA (OR 5.3202, P < 0.0016). Conclusions The most important prognostic markers of OHSS among the examined parameters are the following: AMH, anti-TPO antibodies, and HOMA. Routinely used characteristics, namely age and BMI, possess significantly lower prognostic value and lower reliability. The assessment of OHSS risk in women undergoing ART should include measurement of AMH, anti-TPO antibodies and HOMA. Support None.
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The effect of ovarian stimulation with human menopausal gonadotropin (hMG) for IUI cycles on anti-Mullerian hormone reserve levels Objective Infertility in Indonesia is increasing. According to a report from the Ministry of Health of Indonesia in 2010, approximately 12% couples in reproductive age have fertility problems. The objective of this study is to analyze the effect of ovarian stimulation with clomifen citrate (CC) combine with human menopausal gonadotropine (hMG) on AMH levels in patients undergoing IUI. Materials and Methods This study compared AMH levels preand post-ovarian stimulation in participants who received CC + hMG in IUI compared to CC only in 40 patients undergoing IUI, divided into 20 subjects in each group. This study has conducted at Asri Medical Center, Universitas Muhammadiyah Yogyakarta from 2015 to 2016. AMH levels measured were pre-and post-stimulation taken on the day of HCG evaluation in each group. Results 40 patients were eligible for study. Twenty patients undergoing IUI with CC and 20 patients with CC combine with hMG. The mean age of patients was 30.3 ± 5 years, the mean duration of infertility 2.1 ± 3.7 years. The mean BMl 20.9 ± 5.4 kg/ml, medium AMH level pre-stimulation in group CC without hMG was 3.5 ng/ml and group with hMG was 4.2 ng/ml. Total dosage of FSH in both group used was 3747.5 ± 1086.2 IV/day. The mean duration of ovarian stimulation was 9 ± 3 days. In subjects with CC only, 12 patients (60%) had AMH level decreased, 8 patients (40%) were not.
In subject with CC + hMG 11 patients (55%) had AMH level decreased, 9 patients (45%) were not. Result showed the decrease in AMH levels was not statistically significant (p = 0.387). AMH levels pre-stimulation in group CC only = median 4.8 ng/ml (range 2.2-5.7), post-stimulation = median 4.0 ng/ml (range 2.4-5.6). AMH levels pre-stimulation in group CC + hMG median 3.3 ng/ml (range 1.7-5.2), poststimulation median 4.0 (range 2.4-5.4). Conclusions AMH levels decreased following ovarian stimulation with hMG but without statistical significance indicating that ovarian stimulation in IUI cycles has no effect on the ovarian reserve. Support None.
